SAN DIEGO--(BUSINESS WIRE)--MultiCell Technologies, Inc. (OTCBB:MCET), developing first-in-class drugs based on advanced immune system modulation and other proprietary technologies, announced the availability of a new interview in which Chief Executive Officer Dr. Stephen Chang discusses recent key achievements and breakthroughs with online investor information service CEOcast.com.
